Note: Ingredients listed on restricted chemical lists
EC/CAS
3290-92-4
Name of the chemical
1,1,1-trimethylolpropane trimethacrylate
Concentration
<2.5%
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
<0.25%
EC/CAS
131-57-7
Name of the chemical
Benzophenone-3; Oxybenzone
Concentration
N/A
General Information
Version
6 (replaces version 5
Revision date
2023-05-08
Product name
Dyract eXtra
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
49-(0)7531-583-0
Icons in SDS
Company Information
company name
Dentsply DeTrey GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info-sdb@dentsplysirona.com
GHS Information
Signal word
Hazard-determining components of labelling
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
- Classification
2.2 Label elements
- Labelling
Hazard pictograms
GHS07
Signal word
Hazard-determining components of labelling Esterification products of 4,4'-isopropylidenediphenol, ethoxylated and 2-methylprop-2-enoic acid Butan-1,2,3,4-tetracarbonsdure di-2-hydroxyethylmethacrylat 2,2 '-ethylenedioxydiethyl dimetharcylate
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P273 Avoid release to the environment. P2850 Wear protective gloves / eye protection / face protection. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333+P313 PSO1 [f skin irritation or rash occurs: Get medical advice/attention. Dispose of contents/container in accordance with local/regional/national/international regulations. (Contd. on page 2) GB— (Contd. of page 1)
Additional information
As this product is a intended for use by medical device in the meaning of Directive 93/42/EEC and regulation (EC) 2017/7435 and the end consumer and is applied in an invasive manner or body contact, it is exempt from the labelling requirements
PBT Substances
Not applicable. - vyPvB Not applicable
